CircHECTD1 mediates pulmonary fibroblast activation via HECTD1.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319891558
- By:
- Publication type:
- Article
Works matching IS 20406223 AND DT 2019 AND VI 10
Results: 108
1
2
Sildenafil improves exercise capacity in patients with cystic fibrosis: a proof-of-concept clinical trial.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319887879
- By:
- Publication type:
- Article
3
Neuromuscular electrical stimulation-enhanced rehabilitation is associated with not only motor but also somatosensory cortical plasticity in chronic stroke patients: an interventional study.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319889259
- By:
- Publication type:
- Article
4
The effectiveness and safety of full-dose versus half-dose corticosteroid plus renin-angiotensin system blockers for IgA nephropathy.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319887875
- By:
- Publication type:
- Article
5
The effectiveness and safety of full-dose versus half-dose corticosteroid plus renin-angiotensin system blockers for IgA nephropathy.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319887875
- By:
- Publication type:
- Article
6
Current approach to the diagnosis of atherosclerotic coronary artery disease: more questions than answers.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319884819
- By:
- Publication type:
- Article
7
The responsiveness of the Manchester Chronic Obstructive Pulmonary Disease Fatigue Scale to pulmonary rehabilitation.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319882206
- By:
- Publication type:
- Article
8
Symptoms and exacerbations in asthma: an apparent paradox?
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319884387
- By:
- Publication type:
- Article
9
Stromal cell-derived factor-1 as a potential therapeutic target for osteoarthritis and rheumatoid arthritis.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319882531
- By:
- Publication type:
- Article
10
Common risk factors for major noncommunicable disease, a systematic overview of reviews and commentary: the implied potential for targeted risk reduction.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319880392
- By:
- Publication type:
- Article
11
Contributors, risk associates, and complications of frailty in patients with chronic kidney disease: a scoping review.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319880382
- By:
- Publication type:
- Article
12
The updated PIM-Taiwan criteria: a list of potentially inappropriate medications in older people.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319879602
- By:
- Publication type:
- Article
13
Current approach to the diagnosis of atherosclerotic coronary artery disease: more questions than answers.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319884819
- By:
- Publication type:
- Article
14
Symptoms and exacerbations in asthma: an apparent paradox?
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319884387
- By:
- Publication type:
- Article
15
Stromal cell-derived factor-1 as a potential therapeutic target for osteoarthritis and rheumatoid arthritis.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319882531
- By:
- Publication type:
- Article
16
The responsiveness of the Manchester Chronic Obstructive Pulmonary Disease Fatigue Scale to pulmonary rehabilitation.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319882206
- By:
- Publication type:
- Article
17
Common risk factors for major noncommunicable disease, a systematic overview of reviews and commentary: the implied potential for targeted risk reduction.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319880392
- By:
- Publication type:
- Article
18
Contributors, risk associates, and complications of frailty in patients with chronic kidney disease: a scoping review.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319880382
- By:
- Publication type:
- Article
19
The updated PIM-Taiwan criteria: a list of potentially inappropriate medications in older people.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319879602
- By:
- Publication type:
- Article
20
The prevalence of obesity and overweight, associated demographic and lifestyle factors, and health status in the adult population of Jeddah, Saudi Arabia.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319878997
- By:
- Publication type:
- Article
21
Is e-cigarette use associated with coronary heart disease and myocardial infarction? Insights from the 2016 and 2017 National Health Interview Surveys.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319877741
- By:
- Publication type:
- Article
22
Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit–harm balance modeling study.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319877745
- By:
- Publication type:
- Article
23
The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319875305
- By:
- Publication type:
- Article
24
n-3 PUFAs reduce tumor load and improve survival in a NASH-tumor mouse model.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319872118
- By:
- Publication type:
- Article
25
The prevalence of obesity and overweight, associated demographic and lifestyle factors, and health status in the adult population of Jeddah, Saudi Arabia.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319878997
- By:
- Publication type:
- Article
26
Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit–harm balance modeling study.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319877745
- By:
- Publication type:
- Article
27
Is e-cigarette use associated with coronary heart disease and myocardial infarction? Insights from the 2016 and 2017 National Health Interview Surveys.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319877741
- By:
- Publication type:
- Article
28
The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319875305
- By:
- Publication type:
- Article
29
n-3 PUFAs reduce tumor load and improve survival in a NASH-tumor mouse model.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319872118
- By:
- Publication type:
- Article
30
Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319870013
- By:
- Publication type:
- Article
31
Advanced virtual reality-based rehabilitation of balance and gait in clinical practice.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319868379
- By:
- Publication type:
- Article
32
Noninvasive imaging assessment of rehabilitation therapy in heart failure with preserved and reduced left ventricular ejection fraction (IMAGING-REHAB-HF): design and rationale.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319868376
- By:
- Publication type:
- Article
33
Combined melatonin and poricoic acid A inhibits renal fibrosis through modulating the interaction of Smad3 and β-catenin pathway in AKI-to-CKD continuum.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319869116
- By:
- Publication type:
- Article
34
Tildrakizumab in the treatment of psoriasis: latest evidence and place in therapy.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319865658
- By:
- Publication type:
- Article
35
New therapeutic insights into radiation-induced myocardial fibrosis.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319868383
- By:
- Publication type:
- Article
36
Dietary compounds as potential modulators of microRNA expression in psoriasis.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, n. 12, p. 1, doi. 10.1177/2040622319864805
- By:
- Publication type:
- Article
37
Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319870013
- By:
- Publication type:
- Article
38
Combined melatonin and poricoic acid A inhibits renal fibrosis through modulating the interaction of Smad3 and β-catenin pathway in AKI-to-CKD continuum.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319869116
- By:
- Publication type:
- Article
39
New therapeutic insights into radiation-induced myocardial fibrosis.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319868383
- By:
- Publication type:
- Article
40
Advanced virtual reality-based rehabilitation of balance and gait in clinical practice.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319868379
- By:
- Publication type:
- Article
41
Noninvasive imaging assessment of rehabilitation therapy in heart failure with preserved and reduced left ventricular ejection fraction (IMAGING-REHAB-HF): design and rationale.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319868376
- By:
- Publication type:
- Article
42
Tildrakizumab in the treatment of psoriasis: latest evidence and place in therapy.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319865658
- By:
- Publication type:
- Article
43
Comparing iStent versus CyPass with or without phacoemulsification in patients with glaucoma: a meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- Letter
44
Dietary compounds as potential modulators of microRNA expression in psoriasis.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319864805
- By:
- Publication type:
- Article
45
Effect of statin treatment on circulating malondialdehyde concentrations: a systematic review and meta-analysis.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319862714
- By:
- Publication type:
- Article
46
HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319862697
- By:
- Publication type:
- Article
47
Use of nonselective β blockers after variceal eradication in cirrhotic patients undergoing secondary prophylaxis of esophageal variceal bleeding: a critical review of current evidence.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319862693
- By:
- Publication type:
- Article
48
Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319862691
- By:
- Publication type:
- Article
49
Physical therapy treatment in children with cerebral palsy after single-event multilevel surgery: a qualitative systematic review. A first step towards a clinical guideline for physical therapy after single-event multilevel surgery.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319854241
- By:
- Publication type:
- Article
50
Lactobacillus rhamnosus GG attenuates tenofovir disoproxil fumarate-induced bone loss in male mice via gut-microbiota-dependent anti-inflammation.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319860653
- By:
- Publication type:
- Article